Skip to content
Screener

Xtant Medical Holdings XTNT Q4 2025 Annual earnings

Reported March 31, 2026 · Before market open

Revenue$32.4MBeat by $1.6M
EPS$0.00Beat by $0.01
Revenue estimate$30.8M
EPS estimate-$0.00

Next report

Nov 10, 2026 (in 2 months)
Revenue estimate$25.5M
EPS estimate-$0.03

Financials

Q4 2025

Income statement

See full
Revenue$32.4M+2.7%
Gross profit$17.8M+10.8%
Net income$57.0K+102%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$17.3M+179%
Total debt$17.9M-22.4%
Total equity$51.0M+18.6%
Total assets$94.1M+0.3%

Cash flow

See full
Operating cash flow$5.4M—
CapEx$395.0K-41.2%
Free cash flow$5.0M+71,314%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$109.76M+78.2%
Enterprise value$110.3M+40.7%
P/E22.1×—
P/S0.8×+0.3×

Profitability

See full
Gross margin62.9%+4.8pp
Net margin3.7%+2.1pp
FCF margin7.6%+4.6pp

Returns & leverage

See full
Return on equity10.6%+6.0pp
Debt / equity0.4×-0.2×
Current ratio2.7×+0.3×

Segments

By product

See full
Orthobiologics$18.3M0.0%
Spinal Implant$9.4M-19.7%

FAQ

When did Xtant Medical Holdings report Q4 2025 earnings?
Xtant Medical Holdings (XTNT) reported Q4 2025 earnings on March 31, 2026 before market open.
What were Xtant Medical Holdings's Q4 2025 revenue and EPS?
Xtant Medical Holdings reported revenue of $32.4M and eps of $0.00 for Q4 2025.
Did Xtant Medical Holdings beat estimates in Q4 2025?
Revenue beat the consensus estimate of $30.8M by $1.6M. EPS beat the consensus estimate of $-0.00 by $0.01.
How did Xtant Medical Holdings's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 2.7% from $31.5M a year earlier.
Where can I find Xtant Medical Holdings's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001493152-26-013788) and the 10-K periodic report (0001493152-26-013792) directly on SEC EDGAR. The filing index links above go to sec.gov.